Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR‐ABL inhibitor use by using an adverse drug event reporting database

Breakpoint cluster region‐Abelson murine leukemia (BCR‐ABL) inhibitors markedly improve the prognosis of chronic myeloid leukemia. However, high treatment adherence is necessary for successful treatment with BCR‐ABL inhibitors. Therefore, an adequate understanding of the adverse event profiles of BC...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Okada, Naoto, Niimura, Takahiro, Zamami, Yoshito, Hamano, Hirofumi, Ishida, Shunsuke, Goda, Mitsuhiro, Takechi, Kenshi, Chuma, Masayuki, Imanishi, Masaki, Ishizawa, Keisuke
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Clinical Cancer Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6346261/
https://ncbi.nlm.nih.gov/pubmed/30561126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1920
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items